News from the healthcare data industry
Data analytics company run by Paul Drayson says money could run out in weeks unless it finds emergency funding Julia KolleweFri 14 Jan 2022 13.55 EST Shares in Sensyne Health plummeted after the healthcare technology company run by Paul Drayson, the former UK science and defence minister, said it could run out…
SAN FRANCISCO, Jan. 14, 2022 /PRNewswire/ — Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights from an exclusive real-world data network, today announced a $150 million Series E funding round led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Novo Growth, the growth-stage investment arm of…
Tempus, a leader in artificial intelligence and precision medicine, today announced the commencement of an open label phase II study, in collaboration with GlaxoSmithKline (GSK) to evaluate the efficacy and safety of ZEJULA (niraparib), a poly (ADP-ribose) polymerase (PARP) inhibitor used for patients with advanced or metastatic solid tumors and a germline…
The Palantir Certification Program will provide an opportunity for users to highlight their Foundry knowledge, skills, and abilities, while their employers will be able to accelerate their transformation by identifying and scaling Foundry users. Palantir customers will be able to increase the impact of Palantir’s software by leveraging more of…
Immune checkpoint inhibitors, which strengthen the immune response against tumor cells, have become standard of care for many patients with advanced cancers; however, the medications can often cause side effects, most commonly affecting the skin. A new study led by researchers at Massachusetts General Hospital (MGH) and published in JAMA Dermatology indicates…
PORTLAND, ORE. (PRWEB) JANUARY 12, 2022 Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting. Through the partnership, Maya’s Real World Evidence Platform will be one…
PHILADELPHIA and SAN FRANCISCO, Jan. 13, 2022 (GLOBE NEWSWIRE) — Proscia, the leader in digital and computational pathology solutions, and Datavant, the leader in helping organizations securely connect health data, today announced a partnership that will provide life sciences companies with digitized pathology data to power the development of novel therapeutics and…
This investment accelerates Alira Health’s plan to deliver patient-centric, technology-enabled healthcare solutions. January 13, 2022 09:00 AM Eastern Standard Time FRAMINGHAM, Mass.–(BUSINESS WIRE)–Alira Health (www.alirahealth.com), a global technology-enabled healthcare consultancy, announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. Alira Health intends…
SEATTLE, Jan. 12, 2022 /PRNewswire/ — Curta, a growing provider of health economics and outcomes research products and services, today announced that Sean D. Sullivan, BSPharm, PhD, Scott Ramsey, MD, PhD, David Veenstra, PharmD, PhD, and Josh Carlson, MPH, PhD have joined as partners. These four internationally recognized experts have shaped the field of health economics. They…
Historically, drug researchers have relied on methods such as focus groups, interviews and questionnaires for first-person accounts of patient-reported outcomes, views, symptoms, use of competitive products and other relevant data points. These methods provide valuable data but are costly and resource intensive, and social media has emerged as a lower…